Asia-Pacific Acute Myeloid Leukemia Treatment Market Share

Market Share of Asia-Pacific Acute Myeloid Leukemia Treatment Industry

The market for acute myeloid leukemia treatment in the Asia-Pacific is moderately competitive and comprises global players. Some of the key players in this market are Novartis AG, Pfizer Inc., Teva Pharmaceuticals, and AbbVie Inc., among others. With the rising focus of pharmaceutical companies to provide better therapeutics for cancer, it is believed that more companies will penetrate the market in the near future.

Asia-Pacific Acute Myeloid Leukemia Treatment Market Leaders

1. AbbVie Inc.

2. Pfizer Inc.

3. Teva Pharmaceutical

4. Sun Pharmaceutical Industries Ltd

5. Novartis AG

*Disclaimer: Major Players sorted in no particular order